Tandem Diabetes (TNDM) announced that the U.S. Food and Drug Administration has cleared the Android version of the Tandem Mobi mobile app. The app enables users to manage their diabetes directly from their personal, compatible Android smartphone. A limited release is expected to start in December 2025, followed by commercial availability in early 2026.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Tandem Diabetes Care Q3 2025 Earnings: Record Sales & Growth
- Tandem Diabetes price target raised to $16 from $15 at Stifel
- Tandem Diabetes price target raised to $16 from $14 at Goldman Sachs
- Tandem Diabetes price target raised to $18 from $16 at Mizuho
- Tandem Diabetes Care: Strong Buy Rating Backed by Strategic Growth Initiatives and Attractive Valuation